Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-C-5739 | DMSNs coated CdTe Quantum Dots (50-60nm) | Dendritic mesoporous silica nanoparticles (DMSNs) not only have a three-dimensional dendritic skeleton and a large central radial emission mesoporous structure, but also have a variable pore surface structure, larger specific surface area, and higher loading capacity. As carriers, they can effectively load large molecule proteins, small molecule drugs, and luminescent compounds. The special multi-level structure and co loading capacity of this material demonstrate potential application prospects in collaborative therapy applications. | price> |
R-M2-9757 | DMG-PEG2K-Chitosan | DMG-PEG2K-Chitosan,1,2-Dimyristoyl-sn-glycerol-PEG2000-Chitosan was incorporated into lipid nanoparticles to provide a chitosan-coated surface for improved cellular uptake and nucleic acid binding, while maintaining colloidal stability through PEG shielding. It is typically designed for nanoparticle surface modification, mucoadhesion, or biocompatible delivery systems. | price> |
R-C-5740 | Perfluorononanoic acid-PAMAM-SS-PEG | PFNA-PAMAM-SS-PEG combines the hydrophobic properties of PFNA, the encapsulation capabilities of PAMAM, the controlled release mechanism of the disulfide bonds, and the advantages of PEGylation. This conjugate offers a platform for the development of targeted drug delivery systems, where the payload can be efficiently encapsulated within the dendrimer and released in a controlled manner in response to the reducing cellular environment. | price> |
R-M2-9758 | Chitosan2K-GSNO | Chitosan2K-GSNO/Chitosan2000-GSNO(S-nitrosoglutathione) is a nitric oxide (NO) donor-conjugated chitosan derivative,where GSNO (S-nitrosoglutathione) is covalently or ionically linked to low molecular weight chitosan (~2 kDa). Chitosan2k-GSNO was developed as a mucoadhesive nitric oxide-releasing polymer for antimicrobial wound healing.The conjugate enabled sustained NO release and improved retention at the application site. | price> |
R-C-5741 | DSPE-PEG2000-MMP(FITC) | The inclusion of Matrix metalloproteinases in DSPE-PEG-MMPs allows for specific enzymatic degradation of the liposomal nanocarrier at the tumor site. This enzyme-sensitive feature enables the triggered release of the encapsulated cargo,such as drugs or imaging agents, in response to the MMP activity present.The incorporation of the Fluorescein dye in DSPE-PEG-MMPs allows for real-time tracking and visualization of the nanocarrier within the biological system.This fluorescent labeling facilitates the assessment of distribution,uptake, and release of the liposomes in preclinical studies. | price> |
R-M2-9759 | Polyglutamic acid 10K-GSNO | Polyglutamic acid 10K-GSNO/PGA10k-GSNO is a biodegradable nitric oxide (NO) donor polymer conjugate, in which S-nitrosoglutathione (GSNO) is incorporated into poly(r-glutamic acid) with an average molecular weight of ~10 kDa. PGA10k-GSNO was incorporated into a hydrogel matrix for localized NO release in wound healing applications, showing enhanced antibacterial effects and tissue regeneration. | price> |
R-C-5742 | DSPE-PEG2000-iRG(RB) | DSPE-PEG-iRG (RB) is a lipid-polyethylene glycol (PEG) conjugate molecule that is widely used in targeted drug delivery systems, such as liposomes or nanoparticles.rhodamine B, which is conjugated to the DSPE-PEG2000-iRG molecule. This dye allows for visualization and tracking of the delivery system in vivo. | price> |
R-M2-9760 | DMG-TK-PEG2K-Mal CHHSSSARC | DMG-TK-PEG2K-Mal CHHSSARC is a coupling molecule with lipid anchoring, PEG protection, ROS responsive release, and targeting/transmembrane peptide function. It can be used for targeted delivery systems such as nanoparticles or liposomes. | price> |
R-M1-8126 | Ac-(EIAALEK)3-CONH2 | Ac-(EIAALEK)3-CONH2 for fusion research. | price> |
R-C-5743 | DOPE-(FITC)CPVLDLFRELLNELLEALKQKLK | DOPE-(FITC)CPVLDLFRELLNELLEALKQKLK is a peptide-lipid conjugate molecule used in drug delivery and imaging applications.DOPE stands for 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, which is a lipid component that can self-assemble into liposomes or lipid nanoparticles.FITC refers to fluorescein isothiocyanate,a widely used fluorescent dye that is covalently attached to the DOPE molecule. | price> |
R-M2-9761 | DMG-TK-PEG2K-LTHVVWL | DMG-TK-PEG2k-LTHVVWL is a lipid–polymer–peptide conjugate composed of a lipophilic DMG anchor, a ROS-sensitive thioketal linker, a polyethylene glycol spacer (2 kDa), and a C-terminal hydrophobic peptide (LTHVVWL). This multifunctional molecule is designed for insertion into lipid bilayers or nanoparticles, enabling prolonged circulation, ROS-triggered peptide exposure or drug release, and potential targeting or bio-interactivity mediated by the LTHVVWL peptide segment. | price> |
R-M1-8127 | Ac-(KIAALKE)4-CONH2 | Ac-(KIAALKE)4-CONH2 for fusion research. | price> |
R-C-5744 | (N terminal)Ac-Pro-Leu-Gly-Leu-Ala-Gly-Lys-DOPE(C terminal) | (C-terminal)DOPE-Ac-Pro-Leu-Gly-Leu-Ala-Gly-Lys(N-terminal),(N terminal)Ac-Pro-Leu-Gly-Leu-Ala-Gly-Lys-DOPE(C terminal)is a peptide-lipid conjugate molecule used in drug delivery and imaging applications.At the C-terminal end of the sequence, there is the DOPE component,which is a lipid that can self-assemble into liposomes or lipid nanoparticles. DOPE provides the conjugate with the ability to form lipid-based delivery systems, which are commonly used in drug delivery applications. | price> |
R-M2-9762 | Bisdemethoxycurcumin-PEG2000-TK-CKLVFF | Bisdemethoxycurcumin-PEG2000-TK-CKLVFF is a composite nanocarrier or therapeutic conjugate. Bisdemethoxycurcumin (BDMC): A potent curcuminoid derivative with antioxidant, anti-inflammatory, and anticancer properties.PEG2000-TK (Thioether Ketone linker): A redox-sensitive cleavable linker often used in prodrug or nanocarrier design.CKLVFF peptide: A β-sheet breaker sequence derived from amyloid-β used to inhibit aggregation—often explored in Alzheimer therapy. | price> |
R-M1-8128 | DOX-GA | DOX-GA,Doxorubicin-Glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy. Doxorubicin-Glycyrrhetinic acid is an efficient nanoplatform for targeting drug delivery system for liver cancer. | price> |
R-M2-9763 | Methacrylic acid-TK-PEG-TK-Methacrylic Acid | Methacrylic acid-TK-PEG-TK-Methacrylic Acid is a redox-responsive, polymerizable amphiphilic block molecule.Methacrylic Acid (MAA): A monomer used for free radical polymerization in hydrogels and nanogels.PEG (Polyethylene Glycol): Used for hydrophilicity and biocompatibility.TK (Thioether-Ketone) linker: A redox-sensitive cleavable bond responsive to glutathione (GSH), commonly used in drug delivery or stimuli-responsive materials. | price> |
R-M1-8129 | Mesoporous SiO2 @NaYbF4 nanoparticles | Mesoporous SiO2 @NaYbF4 nanoparticles,Mesoporous silica coated with NaYbF4 nanoparticles is upconversion nanoparticle composites. | price> |
R-M2-9764 | CY5-Wushanicaritin | CY5-Wushanicaritin/Cyanine5-Wushanicaritin is a fluorescently labeled natural compound conjugate, likely synthesized for bioimaging, cellular tracking, or targeted delivery purposes. | price> |
R-M1-8130 | Taxol-biotin | Taxol-biotin,Paclitaxel-biotin from kamulin.Taxol is a semisynthetic analogue of paclitaxel, which can attenuate the effect of bcl-2 and bcl-xL gene expression. Docetaxel blocks G2/M cell cycle and leads to apoptosis. Docetaxel has anti-tumor activity. | price> |
R-C-5747 | DSPE-PEG2000-oncoFAP | DSPE-PEG-oncoFAP is a lipid-polyethylene glycol (PEG) conjugate molecule used in targeted drug delivery and imaging applications. OncoFAP is a peptide specifically designed to target and bind to fibroblast activation protein (FAP), which is overexpressed in the tumor microenvironment. The DSPE-PEG-oncoFAP conjugate combines the properties of DSPE for liposome formation, PEG for increased circulation time in the bloodstream, and oncoFAP for tumor targeting. | price> |